Literature DB >> 2840830

Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus.

J W Gnann1, J Ahlmén, C Svalander, L Olding, M B Oldstone, J A Nelson.   

Abstract

To determine which cells in kidney grafts are infected with human cytomegalovirus (HCMV) before and after transplantation, kidney specimens were studied by in situ hybridization with 35S-labeled DNA probes representing HCMV immediate-early and late genes. Pretransplantation biopsies and serial posttransplantation biopsies were obtained from 7 renal grafts. All of the transplant recipients were HCMV-seronegative at the time of transplantation and all developed primary HCMV infections. HCMV nucleic acids were not detected in biopsies taken from the healthy donor kidneys before transplantation. However, biopsies taken at various intervals after transplantation showed abundant hybridization with HCMV immediate-early and late gene probes. Virtually all of the hybridizing cells were mononuclear inflammatory cells in the interstitial spaces of the kidney. Occasional hybridization was seen with renal tubular or glomerular cells. No cytomegalic cells were seen. Biopsy specimens taken after systemic anti-HCMV chemotherapy with phosphonoformate showed no uniform reduction in HCMV gene expression. These studies demonstrate that the principal HCMV-infected cells in kidneys of renal transplant patients with primary HCMV infections are infiltrating inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840830      PMCID: PMC1880719     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Clinical manifestations of renal allograft derived primary cytomegalovirus infection.

Authors:  R F Betts; R B Freeman; R G Douglas; T E Talley
Journal:  Am J Dis Child       Date:  1977-07

2.  Generalized cytomegalic inclusion disease of the newborn. Localization of inclusions in the kidney.

Authors:  G H Fetterman; F E Sherman; N S Fabrizio; F M Studnicki
Journal:  Arch Pathol       Date:  1968-07

3.  The transplanted kidney as a source of cytomegalovirus infection.

Authors:  M Ho; S Suwansirikul; J N Dowling; L A Youngblood; J A Armstrong
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

4.  Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction.

Authors:  B C Wu; J N Dowling; J A Armstrong; M Ho
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

5.  Viral infections in renal transplant donors and their recipients: a prospective study.

Authors:  H H Balfour; M S Slade; J M Kalis; R J Howard; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1977-05       Impact factor: 3.982

6.  Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood.

Authors:  D J Lang; P A Ebert; B M Rodgers; H P Boggess; R S Rixse
Journal:  Transfusion       Date:  1977 Jul-Aug       Impact factor: 3.157

7.  Cytomegalovirus: Clinical virological correlations in renal transplant recipients.

Authors:  R L Simmons; C Lopez; H Balfour; J Kalis; L C Rattazzi; J S Najarian
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

8.  Cytomegalovirus replicates efficiently in human kidney mesangial cells.

Authors:  M H Heieren; F J van der Woude; H H Balfour
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Comments on CMV infections in renal transplant patients.

Authors:  G A Nankervis
Journal:  Yale J Biol Med       Date:  1976-03

10.  Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.

Authors:  L B Olding; F C Jensen; M B Oldstone
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.

Authors:  T C Wu; R H Hruban; R F Ambinder; M Pizzorno; D E Cameron; W A Baumgartner; B A Reitz; G S Hayward; G M Hutchins
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

Review 3.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 4.  Human cytomegalovirus infection.

Authors:  J G Sissons; L K Borysiewicz
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

Review 5.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

6.  Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.

Authors:  Jamil Mahmud; Michael J Miller; Aaron M Altman; Gary C Chan
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

7.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B.

Authors:  Karl W Boehme; Jasbir Singh; Stuart T Perry; Teresa Compton
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages.

Authors:  J L Lathey; S A Spector
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Human cytomegalovirus productively infects primary differentiated macrophages.

Authors:  C E Ibanez; R Schrier; P Ghazal; C Wiley; J A Nelson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.